09.09.2014 Views

Autism Studies and Related Medical Conditions, January 2009 - TACA

Autism Studies and Related Medical Conditions, January 2009 - TACA

Autism Studies and Related Medical Conditions, January 2009 - TACA

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

patients with classical autism or ASP, or controls. Patients diagnosed with both<br />

autism <strong>and</strong> ASP showed significantly increased levels of EPA ( approximately<br />

200%) <strong>and</strong> DHA ( approximately 40%), <strong>and</strong> significantly reduced levels of ARA (<br />

approximately 20%), 20:3n-6 <strong>and</strong> ARA/EPA ratio in their RBC polar lipids, when<br />

supplemented with EPA-rich fish oils, compared to controls <strong>and</strong> nonsupplemented<br />

patients with autism. Patients with both regressive autism <strong>and</strong><br />

classical autism/Asperger's syndrome had significantly higher concentrations of<br />

RBC type IV phospholipase A2 compared to controls. However, patients with<br />

autism/ASP, who had taken EPA supplements, had significantly reduced PLA2<br />

concentrations compared to unsupplemented patients with classical autism or<br />

ASP.<br />

Bell, J. G., J. R. Sargent, et al. (2000). "Red blood cell fatty acid compositions in a<br />

patient with autistic spectrum disorder: a characteristic abnormality in<br />

neurodevelopmental disorders?" Prostagl<strong>and</strong>ins Leukot Essent Fatty Acids 63(1-2): 21-<br />

5.<br />

The fatty acid compositions of red blood cell (RBC) phospholipids from a patient<br />

with autistic spectrum disorder (ASD) had reduced percentages of highly<br />

unsaturated fatty acids (HUFA) compared to control samples. The percentage of<br />

HUFA in the RBC from the autistic patient was dramatically reduced (up to 70%)<br />

when the sample was stored for 6 weeks at -20 degrees C. However, only minor<br />

HUFA reductions were recorded in control samples stored similarly, or when the<br />

autistic sample was stored at -80 degrees C. A similar instability in RBC HUFA<br />

compositions upon storage at -20 degrees C has been recorded in schizophrenic<br />

patients. In a number of other neurodevelopmental conditions, including<br />

attention deficit hyperactivity disorder (ADHD) <strong>and</strong> dyslexia, reduced<br />

concentrations of RBC HUFA have been recorded. The extent <strong>and</strong> nature of these<br />

aberrations require further assessment to determine a possible common<br />

biochemical origin of neurodevelopmental disorders in general. To facilitate this,<br />

a large scale assessment of RBC fatty acid compositions in patients with ASD,<br />

<strong>and</strong> related disorders, should be performed as a matter of urgency.<br />

Supplementing cells in culture with the tryptophan metabolite indole acrylic acid<br />

(IAA) affected the levels of cellular HUFA <strong>and</strong> prostagl<strong>and</strong>in production. Indole<br />

acroyl glycine (IAG), a metabolite of IAA excreted in urine, is found in high<br />

concentrations in patients with neurodevelopmental disorders including ASD,<br />

ADHD, dyslexia, Asperger's syndrome <strong>and</strong> obsessive compulsive disorder.<br />

Bello, S. C. (2007). "<strong>Autism</strong> <strong>and</strong> environmental influences: review <strong>and</strong> commentary."<br />

Rev Environ Health 22(2): 139-56.<br />

Progress has been slow in identifying pre- <strong>and</strong> post-natal environmental<br />

exposures that might trigger the features that characterize autism. During the<br />

past thirty years, research in the field of autism has been conducted in a setting<br />

in which diagnostic criteria for this condition have changed <strong>and</strong> broadened, <strong>and</strong><br />

differences of opinion regarding diagnostic issues <strong>and</strong> diagnostic terminology<br />

<strong>Autism</strong> <strong>Studies</strong> & <strong>Related</strong> <strong>Medical</strong> <strong>Conditions</strong> – <strong>TACA</strong> © Page 72

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!